Forex Education Symbols

Stock Technical Analysis
Targets Six months: 0.052    One year: 0.064
Supports Support1: 0.028   Support2: 0.023
Resistances Resistance1: 0.045    Resistance2: 0.055 
Pivot Point 0.040 
Moving Averages MA(5): 0.039      MA(20): 0.041 

MA(100): 0.034      MA(250): 0.034 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 23.8      %D(3): 19.0 
RSI RSI(14): 53.0 
52-Week High: 0.055  Low: 0.022  Change(%): 21.2
Average Volume(K) 3-Month: 21599  10-Days: 4250.540039
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
ANP.AX has closed below upper band by 49.2%. Bollinger Bands are 35.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Interested In Antisense Therapeutics Limited (ASX:ANP)? Here's How It ...
Wed, 14 Mar 2018 06:45:00 GMT

Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement ...
Thu, 14 May 2015 23:53:40 GMT

Antisense Therapeutics to commence muscular dystrophy trials
Mon, 26 Jun 2017 22:30:00 GMT

Why Antisense Therapeutics Limited (ASX:ANP) Has Zero-Debt On Its Balance Sheet
Tue, 19 Dec 2017 02:37:30 GMT

Taking a Look Under the Hood at Antisense Therapeutics Ltd (ANP.AX) As Shares ...
Tue, 20 Mar 2018 00:45:00 GMT

Duchenne Muscular Dystrophy – Companies Involved in Therapeutics Development ...
Thu, 01 Mar 2018 11:47:35 GMT

Australia Stocks

Stock Chart Au

Stoxline NZ

Stock Chart NZ

EPS -0.015
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS 1.#IO
Shares Out. (M) 161.56
Shares Float (M) 106.35
Book Value (p.s.) 0.010
PEG Ratio
Profit Margin
Operating Margin -472.19
Return on Assets (ttm) -57.0
Return on Equity (ttm) -111.1
Qtrly Rev. Growth -22.5
Gross Profit (p.s.) 0.002
Sales Per Share
EBITDA (p.s.) -0.014
Qtrly Earnings Growth
Operating Cash Flow (M) -2.58
Levered Free Cash Flow (M) -1.72
P/E -2.67
P/E Growth Ratio
P/BV 4.00
P/CF -2.50